Jade Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -13.3% | -13.3% | -13.1% |
| FY2022 | -40.6% | -40.6% | -38.1% |
| FY2023 | -69.0% | -69.0% | -59.3% |
| FY2024 | 148.8% | 148.8% | -95.6% |
| FY2025 | -38.3% | -38.3% | -36.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -13.3% | -13.3% | -13.1% |
| FY2022 | -40.6% | -40.6% | -38.1% |
| FY2023 | -69.0% | -69.0% | -59.3% |
| FY2024 | 148.8% | 148.8% | -95.6% |
| FY2025 | -38.3% | -38.3% | -36.4% |